Login to Your Account

Pharma: Other news to note

Friday, February 21, 2014
Merck & Co. Inc., of Whitehouse Station, N.J., said the biologics license application for V503 has been accepted for standard review by the FDA.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription